Baillie Gifford & CO Ab Cellera Biologics Inc. Transaction History

Baillie Gifford & CO

$126 Billion
Q2 2024

A detailed history of Baillie Gifford & CO transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 21,911,014 shares of ABCL stock, worth $62 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

21,911,014

Previous 23,180,089 5.47%

Holding current value

$62 Million

Previous $105 Million 38.24%

% of portfolio

0.05%

Previous 0.08%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$2.73 - $4.73 $3.46 Million - $6 Million	-1,269,075 Reduced 5.47%	21,911,014 $64.9 Million
Q1 2024 May 01, 2024	SELL	$4.29 - $5.97 $3.71 Million - $5.16 Million	-864,707 Reduced 3.6%	23,180,089 $105 Million
Q4 2023 Jan 26, 2024	SELL	$3.91 - $5.93 $8.45 Million - $12.8 Million	-2,159,853 Reduced 8.24%	24,044,796 $137 Million
Q3 2023 Nov 13, 2023	SELL	$4.6 - $7.95 $736,469 - $1.27 Million	-160,102 Reduced 0.61%	26,204,649 $121 Million
Q2 2023 Jul 28, 2023	BUY	$5.66 - $7.59 $37 Million - $49.6 Million	6,535,100 Added 32.96%	26,364,751 $170 Million
Q1 2023 May 03, 2023	BUY	$7.31 - $11.18 $971,615 - $1.49 Million	132,916 Added 0.67%	19,829,651 $150 Million
Q4 2022 Jan 24, 2023	BUY	$9.48 - $14.52 $60.1 Million - $92 Million	6,339,067 Added 47.46%	19,696,735 $200 Million
Q3 2022 Oct 27, 2022	BUY	$9.2 - $13.68 $27,167 - $40,397	2,953 Added 0.02%	13,357,668 $132 Million
Q2 2022 Aug 08, 2022	BUY	$5.72 - $10.65 $13.2 Million - $24.6 Million	2,305,950 Added 20.87%	13,354,715 $142 Million
Q1 2022 May 05, 2022	BUY	$7.46 - $14.14 $55.8 Million - $106 Million	7,474,857 Added 209.15%	11,048,765 $108 Million
Q4 2021 Jan 20, 2022	BUY	$12.99 - $17.73 $4.33 Million - $5.91 Million	333,365 Added 10.29%	3,573,908 $51.1 Million
Q3 2021 Oct 19, 2021	BUY	$14.85 - $21.34 $7.65 Million - $11 Million	515,346 Added 18.91%	3,240,543 $64.9 Million
Q2 2021 Aug 02, 2021	BUY	$20.19 - $34.17 $31.7 Million - $53.6 Million	1,569,844 Added 135.88%	2,725,197 $60 Million
Q1 2021 May 06, 2021	BUY	$23.29 - $53.2 $26.9 Million - $61.5 Million	1,155,353 New	1,155,353 $39.2 Million

Others Institutions Holding ABCL

# of Institutions

171

Shares Held

119M

Call Options Held

239K

Put Options Held

200K

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $807M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Account

Baillie Gifford & CO Ab Cellera Biologics Inc. Transaction History